These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16898606)

  • 1. [Use of Rome III criteria for diagnosing irritable bowel syndrome].
    Hattori T; Fukudo S
    Nihon Rinsho; 2006 Aug; 64(8):1425-8. PubMed ID: 16898606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of irritable bowel syndrome on Rome III criteria: a multicenter study.
    Yao X; Yang YS; Cui LH; Zhao KB; Zhang ZH; Peng LH; Guo X; Sun G; Shang J; Wang WF; Feng J; Huang Q
    J Gastroenterol Hepatol; 2012 Apr; 27(4):760-5. PubMed ID: 21929652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disease concept and definition of irritable bowel syndrome].
    Hongo M; Sato Y
    Nihon Rinsho; 2006 Aug; 64(8):1415-9. PubMed ID: 16898604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthropological, demographic and socioeconomic characteristics of irritable bowel syndrome.
    Ebling B; Jurcić D; Gmajnić R; Vcev A; Bilić A; Pribić S
    Coll Antropol; 2011 Jun; 35(2):513-21. PubMed ID: 21755726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensionality of symptom complexes in irritable bowel syndrome and other functional gastrointestinal disorders.
    Alpers DH
    J Psychosom Res; 2008 Jun; 64(6):567-72. PubMed ID: 18501256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III.
    Ersryd A; Posserud I; Abrahamsson H; Simrén M
    Aliment Pharmacol Ther; 2007 Sep; 26(6):953-61. PubMed ID: 17767480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population.
    Schmulson M; Adeyemo M; Gutiérrez-Reyes G; Charúa-Guindic L; Farfán-Labonne B; Ostrosky-Solis F; Díaz-Anzaldúa A; Medina L; Chang L
    Am J Gastroenterol; 2010 Apr; 105(4):925-32. PubMed ID: 20179693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD; Shvartzman P; Friger M; Fich A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Irritable bowel syndrome--irritable bowel or irritable mind?].
    Marlicz W; Zawada I; Starzyńska T
    Pol Merkur Lekarski; 2012 Jan; 32(187):64-9. PubMed ID: 22400184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing pediatric functional abdominal pain in children (4-15 years old) according to the Rome III Criteria: results from a Norwegian prospective study.
    Helgeland H; Flagstad G; Grøtta J; Vandvik PO; Kristensen H; Markestad T
    J Pediatr Gastroenterol Nutr; 2009 Sep; 49(3):309-15. PubMed ID: 19525874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BMW diagnostic criteria for IBS].
    Matsueda K
    Nihon Rinsho; 2006 Aug; 64(8):1431-6. PubMed ID: 16898607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irritable bowel syndrome and the Rome III criteria: for better or for worse?
    Gwee KA
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):437-9. PubMed ID: 17489052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation.
    Malagelada JR
    Int J Clin Pract; 2006 Jan; 60(1):57-63. PubMed ID: 16409429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT; Färkkilä MA
    Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of irritable bowel syndrome among undergraduates in Southeast China.
    Dai N; Cong Y; Yuan H
    Dig Liver Dis; 2008 Jun; 40(6):418-24. PubMed ID: 18339591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome: a population based study.
    Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.
    Korkut E; Bektas M; Oztas E; Kurt M; Cetinkaya H; Ozden A
    Eur J Intern Med; 2010 Oct; 21(5):389-92. PubMed ID: 20816591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.